BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20133995)

  • 1. Retinal hemorrhage in Plasmodium vivax malaria.
    Lee JH; Chin HS; Chung MH; Moon YS
    Am J Trop Med Hyg; 2010 Feb; 82(2):219-22. PubMed ID: 20133995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing Malaria Parasite Clearance Time after Chloroquine Therapy, South Korea, 2000-2016.
    Park SY; Park YS; Park Y; Kwak YG; Song JE; Lee KS; Cho SH; Lee SE; Shin HI; Yeom JS
    Emerg Infect Dis; 2020 Aug; 26(8):1852-1855. PubMed ID: 32687027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactive medical case. A chilly fever.
    Redig AJ; Vaidya A; Price C; Katz JT; Maguire JH
    N Engl J Med; 2014 Oct; 371(16):e24. PubMed ID: 25317891
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India.
    Rishikesh K; Kamath A; Hande MH; Vidyasagar S; Acharya RV; Acharya V; Belle J; Shastry AB; Saravu K
    Malar J; 2015 Aug; 14():310. PubMed ID: 26259839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radical curative efficacy of five-day regimen of primaquine for treatment of Plasmodium vivax malaria in India.
    Yadav RS; Ghosh SK
    J Parasitol; 2002 Oct; 88(5):1042-4. PubMed ID: 12435158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UK malaria treatment guidelines 2016.
    Lalloo DG; Shingadia D; Bell DJ; Beeching NJ; Whitty CJM; Chiodini PL;
    J Infect; 2016 Jun; 72(6):635-649. PubMed ID: 26880088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Status of Plasmodium vivax malaria in the Republic of Korea, 2008-2009: decrease followed by resurgence.
    Yeom JS; Jun G; Kim JY; Lee WJ; Shin EH; Chang KS; Bang JH; Oh S; Kang JY; Park JW
    Trans R Soc Trop Med Hyg; 2012 Jul; 106(7):429-36. PubMed ID: 22560604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral malaria owing to Plasmodium vivax: case report.
    Ozen M; Gungor S; Atambay M; Daldal N
    Ann Trop Paediatr; 2006 Jun; 26(2):141-4. PubMed ID: 16709334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profound thrombocytopenia in Plasmodium vivax malaria.
    Kakar A; Bhoi S; Prakash V; Kakar S
    Diagn Microbiol Infect Dis; 1999 Nov; 35(3):243-4. PubMed ID: 10626136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of symptomatic splenic infarction in vivax malaria.
    Kim A; Park YK; Lee JS; Chung MH; Kim ES
    Korean J Parasitol; 2007 Mar; 45(1):55-8. PubMed ID: 17374979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three unusual presentations of plasmodium vivax malaria.
    Sonkar SK; Uniyal R; Sonkar GK
    Trop Doct; 2011 Oct; 41(4):240-1. PubMed ID: 21926116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic Plasmodium vivax infection in a patient with splenomegaly and severe thrombocytopenia.
    Lacerda MV; Hipólito JR; Passos LN
    Rev Soc Bras Med Trop; 2008; 41(5):522-3. PubMed ID: 19009202
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe Plasmodium vivax malaria, Brazilian Amazon.
    Alexandre MA; Ferreira CO; Siqueira AM; Magalhães BL; Mourão MP; Lacerda MV; Alecrim Md
    Emerg Infect Dis; 2010 Oct; 16(10):1611-4. PubMed ID: 20875292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidemiological and therapeutic aspects of plasmodial infection from Plasmodium vivax].
    Nicolas X; Granier H; Martin J; Klotz F
    Med Trop (Mars); 2000; 60(4):402-8. PubMed ID: 11436600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of vivax malaria on the western border of Thailand.
    Luxemburger C; van Vugt M; Jonathan S; McGready R; Looareesuwan S; White NJ; Nosten F
    Trans R Soc Trop Med Hyg; 1999; 93(4):433-8. PubMed ID: 10674098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of Vanuatu.
    Kinzer MH; Chand K; Basri H; Lederman ER; Susanti AI; Elyazar I; Taleo G; Rogers WO; Bangs MJ; Maguire JD
    Malar J; 2010 Apr; 9():89. PubMed ID: 20370920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short report: chloroquine-resistant Plasmodium vivax in the Republic of Korea.
    Lee KS; Kim TH; Kim ES; Lim HS; Yeom JS; Jun G; Park JW
    Am J Trop Med Hyg; 2009 Feb; 80(2):215-7. PubMed ID: 19190216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reemergence of Plasmodium vivax malaria in the republic of Korea.
    Feighner BH; Pak SI; Novakoski WL; Kelsey LL; Strickman D
    Emerg Infect Dis; 1998; 4(2):295-7. PubMed ID: 9621202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imported tertian malaria resistant to primaquine.
    Na DJ; Han JD; Cha DY; Song IK; Choi HW; Chung EA; Park CW; Choi JS
    Korean J Intern Med; 1999 Jul; 14(2):86-9. PubMed ID: 10461431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of chloroquine followed by primaquine for Plasmodium vivax treatment in Azerbaijan.
    Valibayov A; Abdullayev F; Mammadov S; Gasimov E; Sabatinelli G; Kondrachine AV; Ringwald P
    Acta Trop; 2003 Sep; 88(1):99-102. PubMed ID: 12943984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.